Trends in Anti-Influenza Drug Prescription and Adverse Drug Reaction Reporting After the Lifting of Oseltamivir Prescribing Restrictions in Pediatric Outpatients: An Ecological Study Using the MDV Analyzer® And the Japanese Adverse Drug Event Report Database

Abstract Background Abnormal behavior after oseltamivir administration has been reported in the media; in 2007, the package insert for oseltamivir phosphate was revised to restrict its administration to individuals aged over 10 years. However, in 2018, the age limitation specified in the package ins...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Drugs - Real World Outcomes
المؤلفون الرئيسيون:	Misaki Tokunaga, Daisuke Kikuchi, Aoi Noda, Sachiko Oikawa, Makoto Shiozawa, Hiroaki Hino, Ryosuke Miura, Kensuke Usui, Taku Obara, Kouji Okada
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Adis, Springer Healthcare 2024-01-01
الوصول للمادة أونلاين:	https://doi.org/10.1007/s40801-023-00414-x